Formpipe - Going for growth
2021-02-18 08:05:00
Redeye has a more positive view towards Formpipe following its new growth initiatives and financial targets. We believe it is worth sacrificing some near-term EBIT to strengthen the probability for high growth in Lasernet, which is scalable globally. We raise our 2025 forecasts and Base case.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/